Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma
Selinexor联合低剂量硼替佐米和地塞米松治疗复发或难治性多发性骨髓瘤患者
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2018-06-858852
Bahlis, Nizar J; Sutherland, Heather; White, Darrell; Sebag, Michael; Lentzsch, Suzanne; Kotb, Rami; Venner, Christopher P; Gasparetto, Cristina; Del Col, Aldo; Neri, Paola; Reece, Donna; Kauffman, Michael; Shacham, Sharon; Unger, T J; Jeha, Jacqueline; Saint-Martin, Jean-Richard; Shah, Jatin; Chen, Christine